Discontinued — last reported Q4 '22
Products & Services · Revenue
ADUHELM — Revenue
Biogen ADUHELM — Revenue decreased by 81.3% to $300.00K in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 70.0%, from $1.00M to $300.00K. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2022
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption and demand, while a decrease signals market saturation or competitive pressure.
Detailed definition
This represents the total gross income generated from the sale of a specific product or service within a segment. It is...
Peer comparison
The fundamental metric for comparing product performance across the pharmaceutical industry.
Metric ID:
biib_segment_aduhelm_revenueHistorical Data
7 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $1.60M | $300.00K | $1.00M | $2.80M | $100.00K | $1.60M | $300.00K |
| QoQ Change | — | -81.3% | +233.3% | +180.0% | -96.4% | >999% | -81.3% |
| YoY Change | — | — | — | — | -93.8% | +433.3% | -70.0% |
Range$100.00K – $2.80M
CAGR-67.2%
Avg YoY Growth+89.9%
Median YoY Growth-70.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's aduhelm — revenue?
- Biogen (BIIB) reported aduhelm — revenue of $300.00K in Q4 2022.
- How has Biogen's aduhelm — revenue changed year-over-year?
- Biogen's aduhelm — revenue decreased by 70.0% year-over-year, from $1.00M to $300.00K.
- What does aduhelm — revenue mean?
- The total sales generated by a specific product.